Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Epoetin theta - Teva

Next Previous
Drug Profile

Epoetin theta - Teva

Alternative Names: Biopoin; Eporatio; EpoTheta-Teva; Ratioepo

Latest Information Update: 23 May 2017

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ratiopharm
  • Developer Teva Pharmaceutical Industries
  • Class Antianaemics; Recombinant erythropoietins
  • Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Anaemia

Most Recent Events

  • 23 May 2017 No recent reports on development identified - Registered for Anaemia in Iceland and Norway (SC)
  • 06 Feb 2015 Launched for Anaemia in United Kingdom, Austria, France, Germany, Hungary, Ireland, Netherlands, Poland, Portugal, Czech Republic, Sweden, Spain and Israel (IV) prior to February 2015
  • 06 Feb 2015 Launched for Anaemia in United Kingdom, Austria, France, Germany, Hungary, Ireland, Netherlands, Poland, Portugal, Czech Republic, Sweden, Spain and Israel (SC) prior to February 2015

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top